MDXG
Closed
Mimedx Group Inc
6.22
+0.11 (+1.80%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 6.11
Day's Range: 5.99 - 6.419
Send
sign up or login to leave a comment!
When Written:
3.32
MiMedx Group Inc is a biopharmaceutical company that develops and commercializes regenerative biomaterials and bioimplants. The company's products are used in the areas of wound care, burn care, surgical, orthopedic, spine, sports medicine, ophthalmology, and dentistry. MiMedx's flagship product is AmnioFix, a tissue graft derived from placental tissue that is used to help heal chronic wounds. The company was founded in 2008 and is headquartered in Marietta, Georgia. In 2018, the company faced allegations of accounting fraud and was delisted from the NASDAQ stock exchange. As of 2021, the company is undergoing a restructuring process and is not currently trading on any public stock exchange.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!
When Written:
3.32
MiMedx Group Inc. is a biopharmaceutical company that develops and markets regenerative biomaterials and bioimplants. The company's products are used in the treatment of a variety of conditions, including chronic wounds, burns, and musculoskeletal disorders. MiMedx's products are derived from human placental tissue, which is processed using the company's proprietary Purion process to create a range of biomaterials and bioimplants. The company was founded in 2008 and is headquartered in Marietta, Georgia. It is publicly traded on the NASDAQ stock exchange under the ticker symbol MDXG. In recent years, the company has faced legal and regulatory challenges related to its marketing practices and the processing of its products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








